Systems Biology Opens New Research Pathways
Systems Biologists Are Attacking the Encrypted Messages That Would Allow Us to Predict and Change the Course of Disease
Individual Tumor Profiling
Has Tumor Molecular Profiling Enabled More Effective and Less Toxic Cancer Treatment?
Top 10 Under 40
Up-and-Coming Stars Shine in Biopharma Research and Business
Podcast: FDA’s New Commissioner Hits the Ground Running
Scott Gottlieb, M.D., Commits to Speeding Up Drug Reviews, and Maintaining Safety and Efficacy
Gene Patenting Case Against Myriad Genetics
Today, the Court of Appeals for the Federal Circuit affirmed in part and reversed in part the original decision in Association for Molecular Pathology, et al. v. United States Patent and Trademark Office, et al. Specifically, it stated that Myriad Genetics' composition claims to isolated DNA were valid. What's your thoughts on this latest decision in the long-standing debate over patenting genes.